Skip Navigation
Search Menu
Neurology and Neurosurgery

In This Section      
Print This Page

GLIADEL® Wafers

What is the GLIADEL® wafer?

GLIADEL® wafer

The GLIADEL® wafer is a biodegradable polymer loaded with the chemotherapeutic agent BCNU used for the treatment of recurrent gliomas. It was approved by the FDA in 1995.

After surgical removal of the brain tumor, GLIADEL® wafers are soaked with a chemotherapy drug (BCNU) and are implanted in the space where the tumor was. The wafers destroy the remaining tumor cells.

This is a local drug delivery technique that eliminates the side effects of systemic chemotherapy. Standard chemotherapy affects cancer cells and healthy cells and can cause side effects like fatigue and hair loss.

Request an Appointment

Maryland Patients

Please fax your latest MRI reports and referrals (if necessary) to 410-955-8263.
Request an Appointment

Adult Neurology: 410-955-9441
Pediatric Neurology: 410-955-4259
Adult Neurosurgery: 410-955-6406
Pediatric Neurosurgery: 410-955-7337

 

Traveling for Care?

Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Outside of Maryland (toll free)
410-464-6713

Request an Appointment
Medical Concierge Services

International Patients
+1-410-502-7683

Request an Appointment
Medical Concierge Services

 
blue suitcase